Peer Review History

Original SubmissionOctober 19, 2021
Decision Letter - Dragana Nikitovic, Editor

PONE-D-21-33277Different phylotypes of Propionibacterium acnes cause different modic changes in intervertebral disc degenerationPLOS ONE

Dear Dr. Lu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The authors are called upon to respond to all reviewers' concerns and queries. Specifically, please clarify the categorization of groups and the denomination utilized for the bacterial strain. The MMP related data needs to be further proccessed to incorporate to article. The details regarding experimental proccess need to be clarified at points as well as the utilization of the patient data. Likewise, the disccussion part needs to be edited and specific claims less decisively expressed.

Please submit your revised manuscript by Apr 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Dragana Nikitovic, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. To comply with PLOS ONE submissions requirements, in your Methods section, please provide additional information on the animal research and ensure you have included details on (1) methods of sacrifice, (2) methods of anesthesia and/or analgesia, and (3) efforts to alleviate suffering.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

This work was supported by Fujian Province Natural Science Foundation of China (2019J01051964) and Startup Fund for scientific research, Fujian Medical University.

Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

This work was supported by Province Natural Science Foundation of China (2019J01051964) and Startup Fund for scientific research, Fujian Medical University.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors Manuscript PONE-D-21-33277

Thanks for your submission and the chance to review your work.

It’s an interesting study, using multiple methods: retrieval and culture from surgical intervertebral disc samples from 60 patients undergoing diskectomy; there were P Acnes growth in 18 cases. Different P. Acnes species were identified, and three types were inoculated to three groups of rabbits on the L5-6 disc, having as a control L4-5. Animal spines were imaged q2 weeks via MR and analyzed histologically at 8 weeks. Additionally, discal cells were co-cultured with different types of P Acnes in different concentrations, and MMP expression was measured.

It's an overall well-designed study, interesting and bridging a gap in the field’s knowledge, and have a relevant result (differential effect on the discs of the animal model and culture depending on the P Acnes strain). However, I disagree that different biomechanical environment of the animal model, justifies proposing primates as the next step.

MMP part should be strengthen if it is to be included and reported as results.

I have several observations that may improve the paper:

- P Acnes name has been changed to Cutibacterium acnes, I’d suggest you to at least mention that change either on introduction and/or discussion.

- Animal groups nomination is confusing in the manuscript, sometimes using Groups I, II, III and other times you refer to the bacteria type. Revise.

- How did you measure discal MR signal intensity? Describe your method and the software utilized.

- Page 7, initial paragraph, I guess it should say “Since the avascular…”, not vascular.

- The role of MMP in the pathogenesis of the model is not well introduced, It’s methods for detection are not described and yet, is one of the main results. Please, amend. What’s the hypothetical contribution of MMP to the pathogenesis of MCs?

- Why did you use type IB P Acnes instead of IA1? (actually, you had more cases of IA1). Please, clarify.

- On the part of the discussion, I would moderate the conclusion about type 1-2 P. Acnes producing Modic 1 changes and type 3, Modic 3, since this study has limited numbers of experimental animals for each type. And outside this study, there is no evidence to support such affirmation. I would rephrase this part more on the side of data suggesting that different strains of P Acnes are capable of producing discal damage differently.

- A section of study limitations is missing: low number of subjects (for a prevalence study), not having negative control cultures (i.e. from surgical field), low number of animals per group and thus, using solely the results of the current study, one cannot rule out that P Acnes might be a contaminant. As noted on the discussion as reasons, none of them are contained in this paper. Please add a limitation section on your discussion.

Best,

Reviewer #2: This is well-written well-conducted research in a topic of interest to the spine professionals since colonization by C. acnes in degenerated humans discs is still a question pending an answer. There is both literature supporting this hypothesis and literature going against it. There is even research with molecular analysis of bacterial DNA (NGS) that did not locate C. acnes within the microbiome of degenerated human discs.

In this report, authors isolate C.acnes from human discs after surgical excision and culturing with a 30% positivity rate. Apparently there was no control tissue in this point of the research to determine rate of positive disc colonization by C. acnes, and not contamination during the process. Otherwise, there is controversy as well in controlling culture with surrounding disc tissues (muscles, ligament) since the defect of the annulus could be a way to bacterial spread of the C. acnes outside the disc.

Although this is a weakness to determine rate of true disc colonization, the isolated phylotypes of C. acnes were inoculated into rats intervertebral disc and it does not seem to invalidate this process.

Methods says that patients' pain were accessed but there is no report in the results section about it. If this is not an analyzed measure, it should not be in methods. How long were patients followed after primary surgery?

Percutaneous puncture: it is not clear if after percutaneous puncture of the disc, the rats were opened with a surgical approach to the vertebra and then bone wax was placed at the punctures’ holes. It says that the rat was sutured layer by layer giving the impression that a surgical approach was performed.

This is a good paper considering that is original and brings a new point to the whole C.acnes disc degeneration discussion. It does not prove or gives an answer to the whole C. acnes presence in the disc or its relationship to disc degeneration, but it is original in stating the effects of the C. acnes and some of their different phylotypes in normal disc of rats. Rats spine different biomechanics is a limitation and has been brought into the limitations paragraph.

It is expected that inoculation of any bacteria into a normal disc would lead to infection and inflammatory response and knowing how different types of C. acnes reacts to disc degeneration and its endplates is a good and new data, although the main question on the presence of C. acnes in the human disc remains unanswered.

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mauricio Campos-Daziano MD

Reviewer #2: Yes: Nelson Astur

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Thank you for your letter and the reviwers’ comments concerning our manuscript. We are happy to improve the manuscript based on these helpful and valuable comments from you. We have revised the manuscript according to the editor’s advice, hoping to meet the submission requirements. Revisions in the text are shown using red highlight for additions, and strikethrough font for deletions. The responses to the reviewer's comments are presented in the response file.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Dragana Nikitovic, Editor

Different phylotypes of Cutibacterium acnes cause different modic changes in intervertebral disc degeneration

PONE-D-21-33277R1

Dear Dr. Lu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Dragana Nikitovic, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thanks for accepting our suggestions to make your manuscript more publishable. I think it would constitute a good piece for bridging the knowledge gaps remaining the C acnes hypothesis.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mauricio Campos Daziano

**********

Formally Accepted
Acceptance Letter - Dragana Nikitovic, Editor

PONE-D-21-33277R1

Different phylotypes of Cutibacterium acnes cause different modic changes in intervertebral disc degeneration

Dear Dr. Lu:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Dragana Nikitovic

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .